StockData

eHealth vs SelectQuote

EHTH and SLQT side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How EHTH and SLQT compare

SelectQuote is the larger company, worth 6.1 times as much as eHealth ($86.6M against $14.1M).

SelectQuote grew revenue faster over the last twelve months (0.42% versus −13.6% for eHealth).

eHealth keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with 4.6% at SelectQuote.

SelectQuote scores higher on the StockData Score (9 against 8 for eHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricEHTHSLQT
Size and price
Market cap$14.1M$86.6M
Share price$0.440$0.490
Change, 1 year−89.4%−69.4%
Change, 5 years−98.2%−94.7%
Beta (5Y)1.602.17
Employees1,6651,900
StockData Score
Total score89 (better)
Valuation score22
Growth score23 (better)
Performance score23 (better)
Health score2 (better)1
Dividend score00
Valuation
P/S0.0× (better)0.1×
P/B0.0× (better)0.3×
EV/EBITDA0.8× (better)4.4×
P/FCF–2.7×
FCF yield−122%37.5% (better)
Growth
Revenue growth (TTM)−13.6%0.42% (better)
Revenue growth, 5Y average−1.0%11.7% (better)
Net income growth (TTM)−54.4%17.3% (better)
EPS growth (TTM)−955%−180% (better)
Profitability
Gross margin44.7%55.8% (better)
Operating margin10.6% (better)5.5%
Net margin4.9% (better)4.6%
FCF margin−3.7%2.1% (better)
Return on equity4.6%23.4% (better)
Return on invested capital6.2%10.4% (better)
Financial health
Debt / equity0.23 (better)1.23
Net debt / EBITDA0.55 (better)3.59
Interest coverage3.2× (better)2.0×
Current ratio8.68 (better)2.00
Altman Z-score0.851.54 (better)
Piotroski F-score45 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions56.9%36.4%
Held by insiders11.7%23.8%
Insider net buying, 12 months$188K$548K (better)
Short interest, % of float2.8%1.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.